These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Studies on the pathogenesis of multiple sclerosis. Basic proteins in the myelin and white matter of multiple sclerosis, subacute sclerosing panencephalitis and postvaccinal leucoencephalitis. Riekkinen P, Rinne UK, Savolainen H, Palo J, Kivalo E, Arstila A. Eur Neurol; 1971; 5(4):229-44. PubMed ID: 4399535 [No Abstract] [Full Text] [Related]
25. Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Rodriguez M, Scheithauer BW, Forbes G, Kelly PJ. Mayo Clin Proc; 1993 Jul; 68(7):627-36. PubMed ID: 8350635 [Abstract] [Full Text] [Related]
26. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. Raine CS, Scheinberg L, Waltz JM. Lab Invest; 1981 Dec; 45(6):534-46. PubMed ID: 7321526 [Abstract] [Full Text] [Related]
38. Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. Adams CW, Poston RN, Buk SJ. J Neurol Sci; 1989 Sep; 92(2-3):291-306. PubMed ID: 2809622 [Abstract] [Full Text] [Related]
39. Demyelinating disease in a woman from tropical South America with features of multiple sclerosis and neuromyelitis optica. Clinical, protein chemistry and pathological findings. Howell DA, Jellinek EH, Gavrilescu K. J Neurol Sci; 1968 Sep; 7(1):115-35. PubMed ID: 4301360 [No Abstract] [Full Text] [Related]
40. Neurochemical and morphological studies on demyelination in multiple sclerosis with special reference to etiological aspects. Riekkinen PJ, Rinne UK, Arstila AU. Z Neurol; 1972 Sep; 203(2):91-104. PubMed ID: 4120596 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]